Bob Langer-founded Lyra Therapeutics raises $56M in latest high-end biotech IPO
Another pandemic biotech IPO has sold at the high range.
Lyra Therapeutics said today their public offering, first filed in early March, raised …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
